What’s New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances

Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease, including end-stage kidney disease, and increases the risk of cardiovascular mortality. Although the treatment options for DKD, including angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, sodium-g...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Kimio, Sato, Emiko, Mishima, Eikan, Miyazaki, Mariko, Tanaka, Tetsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820354/
https://www.ncbi.nlm.nih.gov/pubmed/36614011
http://dx.doi.org/10.3390/ijms24010570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820354/
https://www.ncbi.nlm.nih.gov/pubmed/36614011
http://dx.doi.org/10.3390/ijms24010570

Ejemplares similares